Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Water Soluble Bioactives of Nacre Mediate Antioxidant Activity and Osteoblast Differentiation

  • Ratna Chaturvedi ,

    ratna.ch@gmail.com

    Affiliation Department of Biotechnology, Indian Institute of Technology Kharagpur, Kharagpur, West Bengal, India

  • Prajjal Kanti Singha,

    Affiliation Department of Pathology, University of Texas Health Science Center, San Antonio, Texas, United States of America

  • Satyahari Dey

    Affiliation Department of Biotechnology, Indian Institute of Technology Kharagpur, Kharagpur, West Bengal, India

Water Soluble Bioactives of Nacre Mediate Antioxidant Activity and Osteoblast Differentiation

  • Ratna Chaturvedi, 
  • Prajjal Kanti Singha, 
  • Satyahari Dey
PLOS
x

Abstract

The water soluble matrix of nacre is a proven osteoinductive material. In spite of the differences in the biomolecular compositions of nacre obtained from multiple species of oysters, the common biochemical properties of those principles substantiate their biological activity. However, the mechanism by which nacre stimulates bone differentiation remains largely unknown. Since the positive impact of antioxidants on bone metabolism is well acknowledged, in this study we investigated the antioxidant potential of a water soluble matrix (WSM) obtained from the nacre of the marine oyster Pinctada fucata, which could regulate its osteoblast differentiation activity. Enhanced levels of ALP activity observed in pre-osteoblast cells upon treatment with WSM, suggested the induction of bone differentiation events. Furthermore, bone nodule formation and up-regulation of bone differentiation marker transcripts, i.e. collagen type-1 and osteocalcin by WSM confirmed its ability to induce differentiation of the pre-osteoblasts into mature osteoblasts. Remarkably, same WSM fraction upon pre-treatment lowered the H2O2 and UV-B induced oxidative damages in keratinocytes, thus indicating the antioxidant potential of WSM. This was further confirmed from the in vitro scavenging of ABTS and DPPH free radicals and inhibition of lipid peroxidation by WSM. Together, these results indicate that WSM poses both antioxidant potential and osteoblast differentiation property. Thus, bioactivities associated with nacre holds potential in the development of therapeutics for bone regeneration and against oxidative stress induced damages in cells.

Introduction

Nacre is comprised of an organic matrix of biomolecules embedded in crystalline calcium carbonate layers [1]. These biomolecules play crucial role in nucleation, growth induction and inhibition of nacre formation [1,2]. Several matrix proteins have been identified in the nacre and are known to play important role in mineralization. Besides regulating the mineralization process of nacre, water-soluble matrix (WSM) contributes to its biological activities [3,4]. These WSM molecules are evidently involved in cell recruitment, differentiation and stimulation to produce mineralized tissues [5,6]. Due to beneficial biological activities, nacre finds uses in several traditional pharmaceutical preparations, by stimulating bone growth and enhancing bone density. In vivo studies further reveal that pieces of nacre are biologically compatible when implanted in the human and animal bodies and induce bone remodeling, specifically at the interface between the nacre and bone [4,712]. Nonetheless, information about the factors, responsible for its biological activities remains unknown. Proteins, namely P60, P10, and PFMG3 have been identified from Pinctada fucata, which induce osteoblast differentiation in murine pre-osteoblast cells [1315] However, it remains to be seen whether these bioactive molecules are represented in WSM, and if so, then whether they act individually or in harmony with other active molecules in order to induce bone differentiation. Till date, several proteins are identified in nacre from different species that induce osteoblast differentiation, suggesting their common biochemical nature.

Besides induction of bone growth and regeneration, traditionally nacre powder is used in treatments to reduce wrinkles, aging symptoms and sunspots of the skin [1620]. In fact, studies have shown that WSM from shell powder stimulates synthesis of extracellular matrix as well as enhances the production of factors that are implicated in cell-to-cell adhesion and communication in cutaneous fibroblasts [16,18]. In addition, it helps the skin to recover from UV damage and apoptosis [2123]. Together, these studies indicate that WSM could act as potential antioxidant although there is no direct evidence available till date.

Intriguingly, previous studies have also suggested that molecules with antioxidant nature could induce osteoblast differentiation. However, this remains a matter of investigation to see whether antioxidative nature of WSM contributes to its osteoblast differentiation activity. P. fucata is one of the best known pearl producing marine water oysters in the world and the biomolecular composition of its nacre is different from the nacre of fresh water oysters [2426]. Hence, in this study we investigated WSM from P. fucata nacre for both, osteoblast differentiation activity as well as for antioxidant potential.

Methods

Ethics Statement

The in vivo study was approved by the ‘Committee for the Purpose of Control and Supervision of Experiments on Animals’ (CPCSEA), Ministry of Environment and Forest, Government of India and Institutional Animal Ethics Committee, Indian Institute of Technology Kharagpur, India. The experiment was carried out in strict accordance with the recommended protocol provided by the committee.

Extraction of WSM from nacre

WSM was extracted by dissolving 100 mg finely ground powder of nacre in 100 ml of PBS. The solution was stirred overnight at 4°C and then centrifuged at 30,000 g. The supernatant was lyophilized to obtain the WSM in powdered form. This lyophilized powder was dissolved in PBS for use in bioactivity assays.

Dose determination of WSM in murine preosteoblast (MC3T3-E1) and human keratinocyte (HaCaT) cells

For the determination of doses that are biologically compatible for cells, cytotoxic effects of WSM on MC3T3-E1 (obtained from American Type Culture Collection, USA) and HaCaT cells (obtained from National Centre For Cell Science, Pune, India) was evaluated. MC3T3-E1 was grown in minimal essential medium alpha (αMEM), while HaCaT was maintained in Dulbecco’s minimal essential medium (DMEM) with high glucose. Culture media were supplemented with 10% heat inactivated FBS, 100 U ml-1 penicillin and 100 µg ml-1 of streptomycin. Briefly, cells were seeded in 96 well plates at a density of 1 × 104 cells per well in culture media and after reaching the 70% confluency level, cells were treated with WSM in various amounts [0.006, 0.012, 0.025, 0.05, 0.1, and 0.2% (w/v)]. After 24 h of incubation, the media in the wells were removed and replaced with fresh media and incubated for another 24 h followed by MTT assay [27]. Untreated cells served as control in all sets of experiments. Percentage of cell viability was calculated with reference to cell viability in control cells.

Osteoblast differentiation activity of WSM

Alkaline phosphatase (ALP) activity assay.

Bone specific alkaline phosphatase activity was assayed using an alkaline phosphatase assay kit (Cat. No. 104-LL, Sigma). In brief, confluent MC3T3-E1 cells were treated with WSM (0.005, 0.025, and 0.05% w/v) for 24 h. Cells were then harvested by trypsinization and rinsed twice with PBS. The harvested cells were lysed with 200 μl of lysis buffer (2mM MgCl2 and 1% Triton X-100) in a shaker for 30 min at 37°C and were sonicated. Then, 20 μl of lysate were mixed with 100 μl of p-nitrophenyl phosphate solution and were incubated at 37°C for 30 min. The reaction was stopped by adding 50 μl of 3 M NaOH and the final absorbance was measured at 405 nm in a micro plate reader. Alkaline phosphatase activity was calculated using p-nitrophenol as a standard, according to the instructions given in the kit and was expressed as ALP units’ mg-1 of protein min-1. All results were normalized by protein quantitation [28].

Histochemical staining for alkaline phosphatase (ALP).

Histochemical detection of ALP was performed using an ALP staining kit (Cat. No. B6555, Sigma). After 24 h treatment of WSM (0.005, 0.025, and 0.05% w/v), the cells were fixed in 10% formalin for 10 min and washed thrice with PBS (pH 7.4), before the supernatant was replaced by Tris-buffered staining solution (pH 10.4) containing BCIP/ NBT (5- bromo-4-chloro-3-indoly phosphate and nitro blue tetrazolium). After 30 min the color development was stopped by washing with PBS. The staining was examined under a phase contrast microscope and photographed (Leica Microsystems, Germany).

Reverse transcriptase polymerase chain reaction (RT-PCR) for bone differentiation markers: osteocalcin (OCN) and collagen-1 A2 (COL-1A2).

RT-PCR analyses were performed to monitor the transcript levels of osteoblast differentiation markers OCN and COL-1A2. Briefly, MC3T3-E1 cells were incubated with 0.025% (w/v) of WSM for 24 h and total RNA was extracted using TRI reagent. Total RNA was reverse transcribed using Thermo Script RT at 50°C for 20 min in the presence of oligo (dT) primers and RNase inhibitor. The reaction was terminated by heating at 80°C for 10 min. Reverse transcribed RNA (5 µl) containing cDNA was added to the PCR reactions, which were carried out in a final volume of 20 μl buffer containing 200 μM dNTPs, 1.5 mM MgCl2, 20 pmol of each forward and reverse primers, and 1U of Thermus aquaticus DNA polymerase. Glyceraldehyde phosphate dehydrogenase (GAPDH) was used as a housekeeping control. Primers and PCR conditions used are listed in Table 1, as previously reported [29]. Resulting products (20 μl) were fractionated by 1.5% agarose gel electrophoresis and were stained with ethidium bromide (10 mg/ ml) for visualization of amplicons.

GenePrimersPCR conditions
OCNFw:5’-AAGCAGGAGGGCAATAAGGT-3’35 cycles: 94°C 15” , 60°C 1’ , 72°C 1’
Rv: 5’ AGCTGCTGTGACATCCATAC-3’
COL-1A2Fw:5’-GCAATCGGGATCAGTACGAA-3’35 cycles: 94°C 15” , 57.3°C 1’ , 72°C 1’
RV:5’-CTTTCACGCCTTTGAAGCCA-3’
GAPDHFw:5’-CACCATGGAGAAGGCCGGGG-3’35 cycles: 94°C 15” , 55°C 1’ , 72°C 1’
Rv:5’-GACGGACACATTGGGGGTAG-3’

Table 1. Primers and RT-PCR conditions used to amplify the osteoblast differentiation markers OCN, COL-1-A2 and house-keeping gene GAPDH.

Fw: Forward Primers, Rv: Reverse Primers.

CSV
Download CSV

Evaluation of mineralized bone nodules formation by histochemical analysis.

The deposition of hydroxyapatite i.e., bone nodule formation was examined by histochemical staining. For this, the MC3T3-E1 cells were allowed to grow to confluency. The medium was then changed to differentiation media containing α-MEM, 7% FCS, 10 mM β-glycerol phosphate and 50 μg/ ml ascorbic acid. Initial seeding density was 5 × 103 cells per ml in 24 well cell culture plates. Media were replenished every two days with WSM (0.025% w/v). On day 9, cells were washed with PBS twice and analyzed for mineralized bone nodule formation by alizarin red-S [30] and von Kossa- van Gieson staining [31]. The modified van Gieson stain (for matrix-collagen) was then used as a counter stain for von Kossa staining (for mineral-phosphate) [32]. Calcification and mineral phosphate deposits were analyzed by a phase contrast microscope and were photographed (Leica, Germany).

Antioxidant activity of WSM

ABTS radical cation decolorization assay.

The ABTS radical cation decolorization assay was performed as reported earlier [33]. Briefly, ABTS was dissolved in PBS (pH 7.4) to 7 mM concentration, such that ABTS+ radical cation was produced by reaction of ABTS stock solution with 2.45 mM potassium persulfate. The reaction mixture was allowed to stand in dark at room temperature for 12-16 h before use. After 16 h, the ABTS was diluted in PBS to an absorbance value of 0.7 (± 0.02) at 734 nm and was equilibrated at 25°C. Diluted ABTS solution of 900 μl was taken in 1 ml quartz cuvette and 100 μl of WSM (0.5 to 50 mg range) were added and further incubated for 10 min. Thereafter, the absorbance was recorded at 734 nm. PBS was used as a control (100 μl) and as reagent blank (1 ml). L-ascorbic acid was used as the positive control. Decrease in absorbance value i.e. decolorization of the solution determined the scavenging efficiency of WSM and the percentage inhibition was calculated as follows: Percentage inhibition = A-B/A × 100, where A = absorbance of control, B = absorbance of test samples

DPPH free radical scavenging assay.

The DPPH free radical scavenging assay was performed as mentioned earlier [34]. Briefly, 0.002% (w/v) of DPPH was prepared in methanol and 1 ml of this solution was mixed with 100 μl of WSM (0.5 to 50 mg range). Solution mixtures were kept in the dark for 30 min and absorbance was measured at 517 nm. PBS was used as negative control and methanol was used as reagent blank. L-ascorbic acid was used as positive control. Percentage inhibition was calculated using the same formula as described in previous section.

Lipid peroxidation inhibition in mice liver homogenates by thiobarbituric acid (TBA) method.

The lipid peroxidation inhibition assay was performed as described earlier [35]. Briefly, Swiss albino mice (4-5 weeks old female) were sacrificed by cervical dislocation under anesthesia and the liver homogenates were prepared. Livers were homogenized in ice-cold buffer (150 mM KCl, 50 mM Tris-HCl, pH 7.4) and were centrifuged at 12,000 g for 30 min at 4°C. Supernatants were stored in -20°C until used for lipid peroxidation inhibition assays. Lipid peroxidation was quantified by measuring malondialdehyde (MDA). A reaction mixture was prepared by addition of liver homogenates (containing 100-150 μg/ ml protein), 100 μl of WSM (0.5 to 50 mg range), 100 μM FeSO4, 0.1 mM L- ascorbic acid in 1 ml potassium phosphate buffer (0.2 M, pH 7.4) and were incubated at 37°C for 60 min. The reaction was stopped by adding 28% (w/v), TCA (1 ml) and 1% (w/v) TBA (1.5 ml) in succession and the solution was then heated at 100°C in a water bath for 30 min. Reaction mixture was cooled and centrifuged at 3,000 g for 15 min. The absorbance of the supernatant was measured at 532 nm. TBA reacts with MDA to form a TBARS diadduct, a pink chromogen, detectable at 532 nm. Percentage inhibition was calculated according to the formula described earlier. Alpha-tocopherol and PBS were used as positive and negative controls, respectively.

H2O2 induced damage of human keratinocytes and WSM treatment.

The effect of WSM on H2O2 induced oxidative damage in keratinocytes was examined. Firstly, the dose of H2O2 was determined for induction of 50% cell damage. Briefly, HaCaT cells were seeded onto 96 well plates at a density of 1 × 104 cells per well in DMEM high glucose medium containing 10% fetal calf serum. After reaching a 70% confluency level, cells were treated with H2O2, freshly prepared from 30% stock solution (Sigma) for different time periods (1, 6 and 12 h) in various concentrations (0.1, 0.25, 0.5, and 1mM) [36]. Post treatment, the media were replaced with fresh media and were incubated for a further 24 h. Cell viability was analyzed by MTT assay. To determine the effect of WSM on H2O2 treated HaCaT cells, 70% confluent cultures were pretreated with WSM [0.012, 0.025, and 0.05% w/v] for 24 h in the presence of 2% serum (in DMEM high glucose medium) and cells were incubated at 37°C in 5% CO2 humidified atmosphere. The cells were washed with PBS and media were replaced with addition of 0.2 and 0.5 mM of H2O2 for 1h. After 1h of incubation with H2O2, the media were replaced with 10% serum and were further incubated in previous conditions for 24 h. Cell viability was determined by MTT assay and the cell morphology was observed by phase contrast microscopy (Olympus).

UV-B induced damage of human keratinocytes and WSM treatment.

The effect of WSM on UV-B induced damage in keratinocytes was evaluated. For this the cells were grown in 6 well cell culture plates. Before UV irradiation, the media was removed and cells were washed thrice with PBS. To keep cells hydrated, a drop of PBS was added to the cells and then exposed to 30 mJ/ cm2 dose of UV radiation with an emission peak at 312 nm (in the range of UV-B i.e. 290-320 nm) using UV cross linker (Stratagene) equipped with 5 X 8 W tubes and UV meter (Solar light, Inc.). Media was added after irradiation and cells were incubated for 24 h in previous conditions [37]. WSM (0.05% w/v) was added to cell culture media of 24 h old growing cells before the irradiation and were further incubated at 37°C in a humid atmosphere of 5% CO2. Cell morphology was observed by phase contrast microscopy (Olympus). Cell viability was determined using MTT assay.

Statistical analysis

Each experiment was performed in triplicates unless indicated otherwise. The data are represented as mean ± SD and were compared using Tukey’s test. p <0.05 or less was considered to be statistically significant.

Results

WSM is non-cytotoxic to preosteoblasts (MC3T3-E1) and keratinocytes (HaCaT)

To determine the experimental doses of WSM for evaluation of bone differentiation in MC3T3-E1 and UV-protective activity in HaCaT cells, the cytotoxicity of WSM against these cell lines was determined by MTT assay. The cell viability and proliferation rates were not affected by a wide range of concentrations of WSM used and thus indicated its non-cytotoxic nature (Figure 1.A). Upon 48 h of WSM treatment, the average percentage of cell viability remained similar to the untreated cells (control). Thus 0.025 and 0.05% w/v were chosen for further bioactivity screening studies.

thumbnail
Figure 1. WSM enhances alkaline phosphatase activity (ALP) in MC3T3-E1 cells.

A: Effect of WSM on cell viability percentage as measured by MTT assay indicating non-toxic nature of WSM for MC3T3-A1 cells. B: ALP activity measured by ALP assay kit, shows increases in ALP activity after WSM treatment. Data represent mean -SD. *p ≤ 0.001 (vs. control) where n= 6. C: Histochemical staining of MC3T3-A1 cells for ALP activity as observed under phase contrast microscope confirms that WSM increases ALP activity. D: One of the plates (out of triplicate) after ALP staining. Results are expressed as mean -SEM (n= 3). *p ≤ 0.05 (vs. control).

http://dx.doi.org/10.1371/journal.pone.0084584.g001

WSM increases the alkaline phosphatase (ALP) activity

The ALP activity in WSM treated MC3T3-E1 cell line was measured as an early marker of osteoblast differentiation. The ALP activity was increased 7 folds (p< 0.001) upon the treatment of 0.025% (w/v) WSM compared to untreated cells (Figure 1.B). This was further confirmed by activity staining of cellular ALP levels in vitro. The WSM treated cells showed significantly (p< 0.001) higher staining than the untreated cells (Figure 1.C and D).

WSM increases the transcription of osteoblast differentiation marker genes osteocalcin (OCN) and collagen-1 A2 (COL-1A2)

The transcriptional expression levels of two osteoblast differentiation markers i.e. osteocalcin (OCN) and collagen-1 A2 (COL-1A2) were measured using a semiquantitative reverse transcriptase-PCR analysis. We observed a significant increase in the transcription of matrix proteins osteocalcin (OCN) and pro-alpha 2(I) collagen (COL-1A2) in MC3T3-E1 cells after 24 h treatment of WSM (Figure 2A).

thumbnail
Figure 2. WSM up-regulates osteoblast differentiation markers OCN and COL-1-A2 and accelerates bone nodule formation in MC3T3-A1 cells.

A (a-b): Detection of transcriptional levels of osteoblast differentiation marker genes viz. osteocalcin (OCN) and pro-alpha 2(I) collagen (COL-1A2) in RT-PCR of MC3T3-A1 cells, with and without WSM (0.025% w/v) treatment for 24 h. The expression of GAPDH, as housekeeping gene was qualitatively (a) detected by the presence of bands in all experiments. Significant increase in transcript (b) of both the marker genes was observed after WSM treatment. B (a-c): Alizarin red S staining of WSM treated (b) and control (a) MC3T3-E1 cells indicating WSM (0.025%, w/v) accelerates calcium deposition and enhances nodule formation. Black arrows indicate the mineral nodules. Quantification (c) of staining intensities were consistent with the visual observation. C (a-c): von Kossa-von Giesen staining of WSM treated (b) and control (a) MC3T3-E1 cells indicating WSM (0.025% w/v) enhances nodule formation. Black arrows indicate the mineral nodules deposition. Quantification (c) of staining intensities were consistent with the visual observation. Results are expressed as mean -SEM (n= 3). *p ≤ 0.05 (vs. control).

http://dx.doi.org/10.1371/journal.pone.0084584.g002

WSM induced mineralized bone nodule formation

Mineralized bone nodule formation indicates the advanced stages of osteoblast differentiation. To test WSM-induced mineralized bone nodule formation in MC3T3-E1 cells, we performed alizarin Red S and von Kossa-von Giesen staining (Figure 2. B and C). The mineralized nodules appeared in cells treated with 0.025% (w/v) of WSM and were stained heavily with alizarin red S (Figure 2.B). The positive alizarin red S staining indicated the presence of calcified matrix of calcium phosphate, while the untreated cells showed insignificant or no staining (Figure 2.B). Similarly, von Kossa staining revealed the phosphate deposits while van-Giesen staining showed presence of secreted collagen matrix in cell culture media treated with 0.025% (w/v) of WSM (Figure 3.C). However, the untreated cells showed insignificant staining or less staining compared to WSM treated cells (Figure 3.C).

thumbnail
Figure 3. WSM scavenges the ABTS and DPPH free radicals and inhibits lipid peroxidation

Percentage inhibition for scavenging capacity of WSM, assayed with three different methods. i.e. ABTS cation decolorization (at 734 nm), DPPH free radical decolorization (at 517 nm) and lipid peroxidation inhibition by measuring the TBARS production (at 532 nm). Results are expressed as mean -SEM (n= 6). *p ≤ 0.05 (vs. control).

http://dx.doi.org/10.1371/journal.pone.0084584.g003

WSM scavenges ABTS and DPPH free radicals and inhibited lipid peroxidation

To substantiate the antioxidant capacity of WSM to scavenge the ABTS and DPPH free radicals we followed the decolorization of ABTS+ and DPPH. which indicated its capacity to transfer electrons or hydrogen atoms to inactivate these radical cations. For ABTS+ and DPPH. decolorization, IC50 values of 0.08 and 2.5% w/v (WSM, respectively, were recorded (Figure 3). Furthermore, the WSM showed significant (p< 0.05) free radical scavenging activity in a dose dependent manner.

Similarly, the capacity of WSM to inhibit lipid peroxidation induced by iron and L-ascorbic acid in Swiss albino mice liver homogenate was evaluated by measuring the oxidation product TBARS by means of spectrophotometry. The results showed that WSM effectively inhibited the lipid peroxidation in mice liver homogenate by inhibiting TBARS formation in a dose dependent manner with an IC50 value of 0.5% w/v (Figure 3).

WSM reduces H2O2 and UV-B induced damages in human keratinocytes (HaCaT)

The antioxidant activity of WSM was investigated in HaCaT cells by inducing oxidative stress using H2O2 and UV-B irradiation through a cell-based in vitro protection assay. Results indicate that WSM significantly inhibited the H2O2 induced cell death response at a concentration of 0.05% (w/v). H2O2 treatment of keratinocytes induced oxidative stress, as a result ROS was generated, which induced apoptosis in cells that led to cell damage and eventually, cell death. There was a significant (p< 0.05) difference in the cell viability between the control cells, H2O2 treated cells and WSM + H2O2 treated cells (Figure 4.A). Pre-incubation with 0.05% (w/v) WSM, increased the cell viability by 21.2% in 0.25 mM H2O2 treated keratinocytes (Figure 4.B). The morphogenetic changes induced by H2O2 were also shielded by WSM (Figure 4.C). This result suggests that the effect of H2O2 induced cell damage and death was reduced after WSM treatment.

thumbnail
Figure 4. WSM reduces H2O2 and UV-B induced oxidative damage in HaCaT cells.

A: Effect of WSM on cell viability percentage as measured by MTT assay indicating non-toxic nature of WSM for HaCaT cells. B: Effect of WSM on proliferation of HaCaT cells exposed to H2O2 (0.25 and 0.5 mM) for 1 h. C: Effect of WSM on proliferation of HaCaT cells exposed to UV-B (30 and 40 mJ/ cm2). D: Effect of WSM on morphogenetic changes in HaCaT cells induced by H2O2 and UV-B and observed by phase contrast microscopy (200 X). Results are expressed as mean -SEM (n= 6). *p ≤ 0.05 (vs. control).

http://dx.doi.org/10.1371/journal.pone.0084584.g004

Similarly, to determine the effect of WSM on UV-B irradiation induced cell death in keratinocytes, the cells were pre-treated with WSM for 24 h and then irradiated with UV-B (30 mJ/ cm2) followed by incubation in culture media for another 24 h. Results suggest that WSM significantly (p< 0.05) reduced the UV-B irradiation induced cell death at a dose of 0.05% (w/v) (Figure 4.D). It was observed that the morphogenetic changes in keratinocyte cells could be shielded by WSM (Figure 4.C). From these results it was concluded that WSM could inhibit UV-B induced cell death in HaCaT keratinocytes.

Discussion

The osteoinductive potential of WSM from nacre is well known [3,6,3840]. However, most of these evidences are limited to studies on fresh water oysters and a very few marine oysters [25,4148]. Interestingly, in spite of different biomolecular composition of WSM from fresh and marine water oysters, both are able to induce osteoblast differentiation [5,26,4952]. Several proteins have been identified in WSM with osteoinductive properties indicate their common biochemical nature. This suggests, perhaps the osteoinductive molecules present in nacre act through similar molecular mechanisms. In earlier studies, it was found that oxidative stress inhibits osteoblast differentiation and stimulates bone resorption by activating osteoclasts. It has also been suggested that antioxidant biomolecules could induce osteoblast differentiation [53,54]. Furthermore, the normal differentiation pathway of osteoblastic progenitor cells could be inhibited or altered by lipid or lipoprotein oxidation, which can act as potent inducer of osteoclastic differentiation and thus promotes bone resorption, leading to osteoporosis [55,56]. Therefore an efficient therapeutic approach to reduce the risk of osteoporosis would be to use antioxidant molecules that can suppress lipid oxidation levels [53,57]. Since the WSM proteins are known to be highly charged and tend to deviate from normal protein behavior [24,25,46,58], it is possible that these proteins are able to scavenge or quench the free radicals generated during cellular metabolic responses and therefore are able to fasten the differentiation of osteoblasts. Till date, only handful numbers of studies have investigated the antioxidant potential of the shell powder [17,19,22] and there are no reports available that claim the antioxidant property of WSM.

Osteogenesis involves the differentiation of mesenchymal cells into pre-osteoblasts, which in turn differentiate into mature osteoblasts, which finally induce the synthesis and deposition of bone matrix proteins leading to bone formation. ALP is widely recognized as an early marker of osteoblast differentiation, which shoots up during differentiation [59]. In our study, WSM treatment enhanced the ALP activity in murine preosteoblast cells (MC3T3-E1) by seven folds, which is a significant increase as compared to untreated cells (control). Moreover, previous studies suggested that collagen bone matrix proteins account for 90% of the total bone matrix proteins while osteocalcin, a non-collagenous protein, is secreted in the later stages of maturation. In our study, we observed the up-regulation of both the genes, i.e. collagen type 1 (COL-1-A2) and osteocalcin (OCN) transcripts. It confirmed that osteoblast differentiation was induced by WSM treatment in MC3T3-E1 cells. At a later stage of differentiation, the osteocalcin protein is known to have high affinity with hydroxyapatite crystals, which regulates nucleation for bone mineralization [60]. In this study, we observed increased osteocalcin transcript levels after WSM treatment, an indication of differentiation of pre-osteoblasts into mature osteoblasts. In addition to this, we also observed increase in von-Kossa staining that stains phosphate deposition and its counter staining with van-Gieson that stains for collagen matrix. These results indicated in vitro biomineralization. Moreover, increase in alizarin red S staining which stains for calcium deposits confirmed the presence of hydroxyapatite minerals in the cell culture media after the treatment with WSM. Detection of hydroxyapatite is the indication for initiation of bone formation. Hence, our results suggest that WSM promotes the process of differentiation of pre-osteoblasts into osteoblasts. Osteoblasts secret ALP and collagen type-1 proteins at early stage of differentiation and osteocalcin at later stage, and eventually induce hydroxyapatite nodule formation in the culture medium. In usual mineralizing media, osteoblasts take 21 days to differentiate and form nodules [6], whereas WSM treatment induced bone formation in just 9 days, and therefore this study confirms the osteo-promotive nature of WSM.

After the confirmation of osteoblast differentiation property of WSM, we investigated the antioxidant potential of WSM to understand the possible means of cellular protection from oxidative stress. Towards this, we measured the antioxidant potential of WSM in cell free media by ABTS and DPPH free radical scavenging assays and lipid peroxidation inhibition methods. All these three different assay conditions resulted in efficient scavenging of different radical species. Although, the values obtained for IC50 were not directly comparable, WSM showed similar trends to scavenge all the free radicals in a dose dependent manner. Our results, therefore suggest that WSM is able to scavenge free radicals and hence, poses antioxidant properties. Oxidative stress in biological systems is generally induced by ROS and OH. free radicals, which react with a number of biomolecules such as lipids, proteins and nucleic acids and damage them [61]. Confirmation of antioxidant nature of WSM in cell free medium necessitated the experiments on cell-based protective assays to reduce cellular oxidative stress. The method we used to screen the effect of WSM against H2O2 and UV-B induced oxidative damages, employed human keratinocyte cells (HaCaT), an well-established system to test antioxidant properties of molecules [36,37]. Indeed, it was observed that WSM did reduce the harmful effects of oxidative stress induced by H2O2 and UV-B in keratinocytes. These results supported the previous reports about beneficial uses of nacre in skin protection and regenerative therapeutics [20,62]. It has been observed in earlier study that H2O2 induced oxidative stress reduces the osteoblast differentiation in MC3T3-E1 cells [63]. In a recent study antioxidant peptides from P. fucata were found to inhibit the photoaging effect in mice [64]. In addition, enhanced osteogenic differentiation in hydrogel containing nacre powder suggested possible use of nacre in various future tissue-engineering applications [65]. Furthermore, the diversity of shell matrix proteins may be implicated in various biological activities [66]. This study provides strong evidences for the osteogenic and antioxidant properties of WSM, however more detailed study is required to establish the fact that antioxidant molecules of nacre are responsible for osteoblast differentiation. Since WSM is a mixture of molecules further study is required on isolated molecules to evaluate their individual effects. Pending further investigation, the antioxidant nature of WSM molecules is possibly responsible for reducing the osteoclast activity. However, the indications are strong enough in understanding of the holistic effects of WSM on bone physiology and dynamics. Moreover, in vivo studies would validate the potential use of WSM from P. fucata nacre in development of therapeutic products for bone regeneration and skin protection.

Acknowledgments

The authors thank Dr. Syda Rao, Central Marine Fishery Research Institute (CMFRI), India for providing the research materials (nacre of P. fucata).

Author Contributions

Conceived and designed the experiments: RC. Performed the experiments: RC PKS. Analyzed the data: RC SD. Contributed reagents/materials/analysis tools: RC PKS SD. Wrote the manuscript: RC.

References

  1. 1. Mann S (1988) Molecular recognition in biomineralization. Nature 332: 119–124. doi:10.1038/332119a0.
  2. 2. Kröger N (2009) Biochemistry. The molecular basis of nacre formation. Science 325: 1351–1352. doi:10.1126/science.1177055. PubMed: 19679772.
  3. 3. Mouriès LP, Almeida MJ, Milet C, Berland S, Lopez E (2002) Bioactivity of nacre water-soluble organic matrix from the bivalve mollusk Pinctada maxima in three mammalian cell types: fibroblasts, bone marrow stromal cells and osteoblasts. Comp Biochem Physiol B Biochem Mol Biol 132: 217–229. doi:10.1016/S1096-4959(01)00524-3. PubMed: 11997223.
  4. 4. Westbroek P, Marin F (1998) A marriage of bone and nacre. Nature 392: 861–862. doi:10.1038/31798. PubMed: 9582064.
  5. 5. Lamghari M, Almeida MJ, Berland S, Huet H, Laurent A et al. (1999) Stimulation of bone marrow cells and bone formation by nacre: in vivo and in vitro studies. Bone 25: 91S–94S. doi:10.1016/S8756-3282(99)00113-1. PubMed: 10458284.
  6. 6. Rousseau M, Pereira-Mouriès L, Almeida MJ, Milet C, Lopez E (2003) The water-soluble matrix fraction from the nacre of Pinctada maxima produces earlier mineralization of MC3T3-E1 mouse pre-osteoblasts. Comp Biochem Physiol B Biochem Mol Biol 135: 1–7. doi:10.1016/S1095-6433(02)00366-5. PubMed: 12781967.
  7. 7. Atlan G, Delattre O, Berland S, LeFaou A, Nabias G et al. (1999) Interface between bone and nacre implants in sheep. Biomaterials 20: 1017–1022. doi:10.1016/S0142-9612(98)90212-5. PubMed: 10378801.
  8. 8. Liao H, Mutvei H, Hammarström L, Wurtz T, Li J (2002) Tissue responses to nacreous implants in rat femur: an in situ hybridization and histochemical study. Biomaterials 23: 2693–2701. doi:10.1016/S0142-9612(01)00421-5. PubMed: 12059018.
  9. 9. Berland S, Delattre O, Borzeix S, Catonné Y, Lopez E (2005) Nacre/bone interface changes in durable nacre endosseous implants in sheep. Biomaterials 26: 2767–2773. doi:10.1016/j.biomaterials.2004.07.019. PubMed: 15585281.
  10. 10. Silve C, Lopez E, Vidal B, Smith DC, Camprasse S et al. (1992) Nacre initiates biomineralization by human osteoblasts maintained in vitro. Calcif Tissue Int 51: 363–369. doi:10.1007/BF00316881. PubMed: 1458341.
  11. 11. Lopez E, Vidal B, Berland S, Camprasse S, Camprasse G et al. (1992) Demonstration of the capacity of nacre to induce bone formation by human osteoblasts maintained in vitro. Tissue Cell 24: 667–679. doi:10.1016/0040-8166(92)90037-8. PubMed: 1440586.
  12. 12. Wang JJ, Chen JT, Zhang XR (2009) Nacre-induced osteogenesis in the femoral condyles of New Zealand rabbits. NAN Fang Yi Ke da Xue Xue Bao 29: 220–223. PubMed: 19246283.
  13. 13. Zhang C, Li S, Ma Z, Xie L, Zhang R (2006) A novel matrix protein p10 from the nacre of pearl oyster (Pinctada fucata) and its effects on both CaCO3 crystal formation and mineralogenic cells. Mar Biotechnol (NY) 8: 624–633. doi:10.1007/s10126-006-6037-1.
  14. 14. Zhou Y, He Z, Huang J, Gong N, Yan Z et al. (2007) Characterization and in vitro mineralization function of a soluble protein complex P60 from the nacre of Pinctada fucata. Comp Biochem Physiol B Biochem Mol Biol 148: 158–167. PubMed: 17627859.
  15. 15. Wang X, Liu S, Xie L, Zhang R, Wang Z (2011) Pinctada fucata mantle gene 3 (PFMG3) promotes differentiation in mouse osteoblasts (MC3T3-E1). Comp Biochem Physiol B Biochem Mol Biol 158: 173–180. doi:10.1016/j.cbpb.2010.11.004. PubMed: 21109014.
  16. 16. Lopez E, Le Faou A, Borzeix S, Berland S (2000) Stimulation of rat cutaneous fibroblasts and their synthetic activity by implants of powdered nacre (mother of pearl). Tissue Cell 32: 95–101. doi:10.1054/tice.1999.0091. PubMed: 10798323.
  17. 17. Cao G, Xu Z, Wei H, Yao S, Liu Y (1996) Pearl and mother-of-pearl powder in health-care. Zhongguo Zhong Yao Za Zhi 21: 635–638. PubMed: 9772634.
  18. 18. Gu WZ, Zhu G, Zhao YW, TZ (1988) The anti-aging effect of pearl oyster shell powder (POSP). J Tradit Chin Med 8: 247–250. PubMed: 3150022.
  19. 19. Tan W, Qian Z, Gu Z, Pan J, Zhuang X, CY (1988) Experimental Study of the antioxidation effect of pearl. Senoir Medicine J 8: 109–120.
  20. 20. Wang D, Liu J, Yu H, Leng H, Tan L et al. (1994) Research on anti-aging effects of pearl water solution. Chinese Herbal Medicine 25: 203.
  21. 21. Lee K, Kim H, Kim JM, Chung YH, Lee TY et al. (2012) Nacre-driven water-soluble factors promote wound healing of the deep burn porcine skin by recovering angiogenesis and fibroblast function. Mol Biol Rep 39: 3211–3218. PubMed: 21688145.
  22. 22. Torita A, Hasegawa Y, LY (2006) Scallop shell extract promotes recovery from UV-B-induced damage in rat skin epidermal layer. Fish Sci 72: 388–392. doi:10.1111/j.1444-2906.2006.01161.x.
  23. 23. Miyamoto A, Hasegawa Y, TA (2007) The effects of scallop shell extract on collagen synthesis. Fish Sci 73: 1388–1394.
  24. 24. Bédouet L, Marie A, Dubost L, Péduzzi J, Duplat D et al. (2007) Proteomics analysis of the nacre soluble and insoluble proteins from the oyster Pinctada margaritifera. Mar Biotechnol (NY) 9: 638–649. doi:10.1007/s10126-007-9017-1. PubMed: 17641930.
  25. 25. Marie B, Le Roy N, Marie A, Dubost L, Milet C et al. (2009) Nacre Evolution : A Proteomic. Approach - Mater Res Soc Symp Proc1187: 3-8.
  26. 26. Marie B, Marin F, Marie A, Bédouet L, Dubost L et al. (2009) Evolution of nacre: biochemistry and proteomics of the shell organic matrix of the cephalopod Nautilus macromphalus. Chembiochem 10: 1495–1506. doi:10.1002/cbic.200900009. PubMed: 19472248.
  27. 27. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55–63. doi:10.1016/0022-1759(83)90303-4. PubMed: 6606682.
  28. 28. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein dye binding. Anal Biochem 72: 248–254. doi:10.1016/0003-2697(76)90527-3. PubMed: 942051.
  29. 29. Marzia M, Sims NA, Voit S, Migliaccio S, Taranta A et al. (2000) Decreased C-Src Expression Enhances Osteoblast Differentiation and Bone Formation. J Cell Biol 151: 311–320. doi:10.1083/jcb.151.2.311. PubMed: 11038178.
  30. 30. Puchtler H, Meloan SN, Terry MS (1969) On the history and mechanism of alizarin and alizarin red S stains for calcium. J Histochem Cytochem 17: 110–124. doi:10.1177/17.2.110. PubMed: 4179464.
  31. 31. Bhargava U, Bar-Lev M, Bellows CG, Aubin JE (1988) Ultrastructural analysis of bone nodules formed in vitro by isolated fetal rat calvaria cells. Bone 9: 155–163. doi:10.1016/8756-3282(88)90005-1. PubMed: 3166832.
  32. 32. Rungby J, Kassem M, Eriksen EF, Danscher G (1993) The von Kossa reaction for calcium deposits: silver lactate staining increases sensitivity and reduces background. Histochem J 25: 446–451. doi:10.1007/BF00157809. PubMed: 8360080.
  33. 33. Re R, Pellegrini N, Proteggente A, Pannala A, Yang M et al. (1999) Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med 26: 1231–1237. doi:10.1016/S0891-5849(98)00315-3. PubMed: 10381194.
  34. 34. Brand-Williams W, Cuvelier ME, Berset C (1995) Use of a Free Radical Method to Evaluate Antioxidant Activity. Lebenson Wiss Technol 28: 25–30. doi:10.1016/S0023-6438(95)80008-5.
  35. 35. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95: 351–358. doi:10.1016/0003-2697(79)90738-3. PubMed: 36810.
  36. 36. Dash R, Acharya C, Bindu PC, Kundu SC (2008) Antioxidant potential of silk protein sericin against hydrogen peroxide-induced oxidative stress in skin fibroblasts. BMB Rep 41: 236–241. doi:10.5483/BMBRep.2008.41.3.236. PubMed: 18377728.
  37. 37. Dash R, Mandal M, Ghosh SK, Kundu SC (2008) Silk sericin protein of tropical tasar silkworm inhibits UVB-induced apoptosis in human skin keratinocytes. Mol Cell Biochem 311: 111–119. doi:10.1007/s11010-008-9702-z. PubMed: 18214642.
  38. 38. Wang JJ, Chen JT, Yang CL (2007) Effects of soluble matrix of nacre on bone morphogenetic protein-2 and Cbfa1 gene expressions in rabbit marrow mesenchymal stem cells. NAN Fang Yi Ke da Xue Xue Bao 27: 1838–1840. PubMed: 18158997.
  39. 39. Almeida MJ, Milet C, Peduzzi J, Pereira L, Haigle J et al. (2000) Effect of water-soluble matrix fraction extracted from the nacre of Pinctada maxima on the alkaline phosphatase activity of cultured fibroblasts. J Exp Zool 288: 327–334. doi:10.1002/1097-010X(20001215)288:4. PubMed: 11144281.
  40. 40. Sud D, Doumenc D, Lopez E, Milet C (2001) Role of water-soluble matrix fraction, extracted from the nacre of Pinctada maxima, in the regulation of cell activity in abalone mantle cell culture (Haliotis tuberculata). Tissue Cell 33: 154–160. doi:10.1054/tice.2000.0166. PubMed: 11392668.
  41. 41. Bédouet L, Marie A, Dubost L, Péduzzi J, Duplat D et al. (2007) Proteomics analysis of the nacre soluble and insoluble proteins from the oyster Pinctada margaritifera. Mar Biotechnol (NY) 9: 638–649. doi:10.1007/s10126-007-9017-1. PubMed: 17641930.
  42. 42. Suzuki M, Saruwatari K, Kogure T, Yamamoto Y, Nishimura T et al. (2009) An acidic matrix protein, Pif, is a key macromolecule for nacre formation. Science 325: 1388–1390. doi:10.1126/science.1173793. PubMed: 19679771.
  43. 43. Zhang Y, Xie L, Meng Q, Jiang T, Pu R et al. (2003) A novel matrix protein participating in the nacre framework formation of pearl oyster, Pinctada fucata. Comp Biochem Physiol B Biochem Mol Biol 135: 565–573. doi:10.1016/S1095-6433(03)00139-9. PubMed: 12831776.
  44. 44. Blank S, Arnoldi M, Khoshnavaz S, Treccani L, Kuntz M et al. (2003) The nacre protein perlucin nucleates growth of calcium carbonate crystals. J Microsc 212: 280–291. doi:10.1111/j.1365-2818.2003.01263.x. PubMed: 14629554.
  45. 45. Yan Z, Jing G, Gong N, Li C, Zhou Y et al. (2007) N40, a novel nonacidic matrix protein from pearl oyster nacre, facilitates nucleation of aragonite in vitro. Biomacromolecules 8: 3597–3601. doi:10.1021/bm0701494. PubMed: 17929965.
  46. 46. Furuhashi T, Miksik I, Smrz M, Germann B, Nebija D et al. (2010) Comparison of aragonitic molluscan shell proteins. Comp Biochem Physiol B Biochem Mol Biol 155: 195–200. doi:10.1016/j.cbpb.2009.11.007. PubMed: 19932190. Available online at: doi:10.1016/j.cbpb.2009.11.007. Available online at: PubMed: 19932190.
  47. 47. Bédouet L, Schuller MJ, Marin F, Milet C, Lopez E et al. (2001) Soluble proteins of the nacre of the giant oyster Pinctada maxima and of the abalone Haliotis tuberculata: extraction and partial analysis of nacre proteins. Comp Biochem Physiol B Biochem Mol Biol 128: 389–400. doi:10.1016/S1096-4959(00)00337-7. PubMed: 11250534.
  48. 48. Bédouet L, Duplat D, Marie A, Dubost L, Berland S et al. (2007) Heterogeneity of proteinase inhibitors in the water-soluble organic matrix from the oyster nacre. Mar Biotechnol (NY) 9: 437–449. doi:10.1007/s10126-007-7120-y. PubMed: 17393253.
  49. 49. Kim H, Lee K, Ko CY, Kim HS, Shin HI et al. (2012) The role of nacreous factors in preventing osteoporotic bone loss through both osteoblast activation and osteoclast inactivation. Biomaterials 33: 7489–7496. doi:10.1016/j.biomaterials.2012.06.098. PubMed: 22809648.
  50. 50. Rousseau M, Boulzaguet H, Biagianti J, Duplat D, Milet C et al. (2008) Low molecular weight molecules of oyster nacre induce mineralization of the MC3T3-E1 cells. J Biomed Mater Res A 85: 487–497. PubMed: 17729263.
  51. 51. Bai Z, Zheng H, Lin J, Wang G, Li J (2013) Comparative Analysis of the Transcriptome in Tissues Secreting Purple and White Nacre in the Pearl Mussel Hyriopsis cumingii. PLOS ONE 8: e53617. doi:10.1371/journal.pone.0053617. PubMed: 23341956.
  52. 52. Jackson DJ, McDougall C, Woodcroft B, Moase P, Rose RA et al. (2010) Parallel evolution of nacre building gene sets in molluscs. Mol Biol Evol 27: 591–608. doi:10.1093/molbev/msp278. PubMed: 19915030.
  53. 53. Mody N, Parhami F, Sarafian TA, Demer LL (2001) Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic Biol Med 31: 509–519. doi:10.1016/S0891-5849(01)00610-4. PubMed: 11498284.
  54. 54. Bax BE, Alam AS, Banerji B, Bax CM, Bevis PJ et al. (1992) Stimulation of osteoclastic bone resorption by hydrogen peroxide. Biochem Biophys Res Commun 183: 1153–1158. doi:10.1016/S0006-291X(05)80311-0. PubMed: 1567393.
  55. 55. Parhami F, Garfinkel A, Demer LL (2000) Role of lipids in osteoporosis. Arterioscler Thromb Vasc Biol 20: 2346–2348. doi:10.1161/01.ATV.20.11.2346. PubMed: 11073836.
  56. 56. Luegmayr E, Glantschnig H, Wesolowski GA, Gentile MA, Fisher JE et al. (2004) Osteoclast formation, survival and morphology are highly dependent on exogenous cholesterol/lipoproteins. Cell Death Differ 11 Suppl 1: S108–S118. doi:10.1038/sj.cdd.4401399. PubMed: 15017384.
  57. 57. Parhami F (2003) Possible role of oxidized lipids in osteoporosis: could hyperlipidemia be a risk factor? Prostaglandins Leukot Essent Fatty Acids 68: 373–378. doi:10.1016/S0952-3278(03)00061-9. PubMed: 12798657.
  58. 58. Marie B, Zanella-Cléon I, Le Roy N, Becchi M, Luquet G et al. (2010) Proteomic analysis of the acid-soluble nacre matrix of the bivalve Unio pictorum: detection of novel carbonic anhydrase and putative protease inhibitor proteins. Chembiochem 11: 2138–2147. doi:10.1002/cbic.201000276. PubMed: 20815006.
  59. 59. Ouhayoun JP, LL (1997) In vitro induction of osteogenic differentiation from non-osteogenic mesenchymal cells. Biomaterials 18: 989–993. doi:10.1016/S0142-9612(97)00025-2. PubMed: 9212194.
  60. 60. Hunter GK, Hauschka PV, Poole AR, Rosenberg LC, Goldberg HA (1996) Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. Biochem J 317: 59–64. PubMed: 8694787.
  61. 61. Sohal RS, Dubey A (1994) Mitochondrial oxidative damage, hydrogen peroxide release, and aging. Free Radic Biol Med 16: 621–626. doi:10.1016/0891-5849(94)90062-0. PubMed: 8026805.
  62. 62. Noguchi T, Torita A, Hasegawa Y (2007) Purification and characterization of a matrix shell protein from the shell of scallop Patinopecten yessoensis. Fish Sci 73: 1177–1185. doi:10.2331/suisan.73.1177.
  63. 63. Arai M, Shibata Y, Pugdee K, Abiko Y, Ogata Y (2007) Effects of reactive oxygen species (ROS) on antioxidant system and osteoblastic differentiation in MC3T3-E1 cells. IUBMB Life 59: 27–33. doi:10.1080/15216540601156188. PubMed: 17365177.
  64. 64. Wu Y, Tian Q, Li L, Khan MN, Yang X et al. (2013) Inhibitory effect of antioxidant peptides derived from Pinctada fucata protein on ultraviolet-induced photoaging in mice. J Funct Foods 5: 527-538. doi:10.1016/j.jff.2013.01.016.
  65. 65. Flausse A, Henrionnet C, Dossot M, Dumas D, Hupont S et al. (2013) Osteogenic differentiation of human bone marrow mesenchymal stem cells in hydrogel containing nacre powder. J Biomed Mater Res A 101: 3211-3218. PubMed: 23554327.
  66. 66. Miyamoto H, Endo H, Hashimoto N, limura K, Isowa Y, et al. (2013) The diversity of shell matrix proteins: Genome-wide investigation of the pearl oyster, Pinctada fucata. Zoolog Sci 30: 801-816.